| RN4220 |
Restriction deficient lab strain |
[42]
|
| DU5969 |
RN4220aur::lacZ
|
[48]
|
| USA300 LAC |
Hypervirulent pandemic CA-MRSA Los Angeles county clone, clonal complex CC8 spa t008 |
[77], [78]Barry Kreiswirth |
| USA300 |
USA300 LAC cured of antibiotic resistance plasmid |
This study |
| USA300aur::lacZ
|
aur::lacZ from DU5969 transduced into USA300 |
This study |
| USA300sspABC
|
Replacement of sspABC in USA300 with Tcr cassette, using pMJ232 |
This study |
| USA300aur
|
Transduction of aur::lacZ into USA300 |
This study |
| USA300sspABCaur
|
Transduction of aur::lacZ into USA300sspABC
|
This study |
| USA400 |
CA-MRSA fatal pediatric bacteremia, CC1 spa t127 |
[79]
|
| MSSA476 |
CA-MSSA closely related to USA400; pediatric osteomyelitis |
[75]
|
| Newman |
MSSA clinical isolate; routinely used in virulence studies, CC8 spa t008 |
[80], [81]
|
| WBG10049 |
Southwest Pacific Clone of CA-MRSA, CC30 spa t019 |
[82]
|
| MRSA252 |
HA-MRSA; CC30, spa t016 |
[83]
|
| UAMS-1 |
MSSA osteomyelitis, CC30 spa t033 |
[84]
|
| SRI-138 |
MSSA dermatitis CC45 spa t065 |
[85]
|
| SRI-109 |
MSSA dermatitis; CC45 spa t015 |
[85]
|
| PED1–75 |
MSSA pediatric dermatitis; CC5 spa t002 |
[85]
|
| SRI-116 |
MSSA dermatitis; CC1 spa t7404 |
[85]
|
| SRI-142 |
MSSA dermatitis; CC1 spa t4938 |
[85]
|
| PED2–1 |
CA-MRSA pediatric dermatitis; CC97 spa t7398 |
[85]
|
| PED1-53 |
MSSA pediatric dermatitis; CC8 spa t008 |
[85]
|
| L528 |
MSSA infective endocarditis; CC30 spa t033 |
[52]
|
| PED1-37 |
MSSA pediatric dermatitis; CC398 spa t937 |
[85]
|
| pMAD |
Shuttle vector for construction of mutations in Gram-positive bacteria |
[41]
|
| pDG1514 |
Source of Tcr cassette |
[86]
|
| pMJ232 |
pMAD containing Tcr cassette from pDG1514, flanked by BamHI-[sspA-5P]-MluI and EcoRI-[sspC-3P]-BglII |
This study |
